{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:13:05Z","timestamp":1786975985265,"version":"build-2736575974"},"reference-count":23,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007091","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T05:56:47Z","timestamp":1208757407000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["5-alpha-reductase inhibitors for prostate cancer prevention"],"prefix":"10.1002","volume":"2012","author":[{"given":"Timothy J","family":"Wilt","sequence":"first","affiliation":[{"name":"VAMC; General Internal Medicine (111-0); One Veterans Drive Minneapolis Minnesota USA 55417"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"MacDonald","sequence":"additional","affiliation":[{"name":"VAMC; General Internal Medicine (111-0); One Veterans Drive Minneapolis Minnesota USA 55417"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Hagerty","sequence":"additional","affiliation":[{"name":"American Society of Clinical Oncology; Clinical Affairs; 1900 Duke Street Suite 200 Alexandria Virginia USA 22314"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Schellhammer","sequence":"additional","affiliation":[{"name":"Eastern Virginia Medical School; Deoartment of Urology; 6333 Center Drive Bldg. 16 Norfolk Virginia USA 23502"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnett S","family":"Kramer","sequence":"additional","affiliation":[{"name":"National Institutes of Health; 6100 Executive Boulevard Suite 2B03 Bethesda Maryland USA 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,4,23]]},"reference":[{"key":"10.1002\/14651858.CD007091-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.urology.2004.04.084","article-title":"Effect of dutasteride on the detection of prostate cancer in men with benign prostatic hyperplasia","volume":"64","author":"Andriole","year":"2004","journal-title":"Urology"},{"key":"10.1002\/14651858.CD007091-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0090-4295(02)01905-2","article-title":"Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia","volume":"60","author":"Roehrborn","year":"2002","journal-title":"Urology"},{"key":"10.1002\/14651858.CD007091-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/bjc.1998.508","article-title":"The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels","volume":"78","author":"Cote","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1002\/14651858.CD007091-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0022-5347(05)67910-4","article-title":"A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride","volume":"163","author":"Foley","year":"2000","journal-title":"J Urol"},{"key":"10.1002\/14651858.CD007091-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199210223271701","article-title":"The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group","volume":"22","author":"Gormley","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD007091-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pros.2990220403","article-title":"Finasteride (MK-906) in the treatment of benign prostatic hyperplasia","volume":"22","author":"Finasteride Study Group","year":"1993","journal-title":"Prostate"},{"key":"10.1002\/14651858.CD007091-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/147323000203000606","article-title":"Comparison of tamsulosin and finasteride for lower urinary tract symptoms associated with benign prostatic hyperplasia in Korean patients","volume":"30","author":"Lee","year":"2002","journal-title":"J Int Med Res"},{"key":"10.1002\/14651858.CD007091-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/sj.pcan.4500680","article-title":"A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia","volume":"6","author":"Rigatti","year":"2003","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1002\/14651858.CD007091-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD007091-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1056\/NEJMoa030660","article-title":"The influence of finasteride on the development of prostate cancer","volume":"349","author":"Thompson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD007091-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0090-4295(98)00184-8","article-title":"Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial","volume":"52","author":"Andriole","year":"1998","journal-title":"Urology"},{"key":"10.1002\/14651858.CD007091-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0090-4295(02)02114-3","article-title":"Efficacy and tolerability of doxazosin and finasteride, alone or in combination, in treatment of symptomatic benign prostatic hyperplasia: the Prospective European Doxazosin and Combination Therapy (PREDICT) trial","volume":"61","author":"Kirby","year":"2003","journal-title":"Urology"},{"key":"10.1002\/14651858.CD007091-BIB0013|cit13","first-page":"1251","article-title":"Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study)","volume":"155","author":"Nickel","year":"1996","journal-title":"Can Med Assoc J"},{"key":"10.1002\/14651858.CD007091-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199608223350801","article-title":"The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group","volume":"335","author":"Lepor","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD007091-BIB0015|cit15","volume-title":"Cancer Facts & Figures 2007","author":"American Cancer Society","year":"2007"},{"key":"10.1002\/14651858.CD007091-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/01.ju.0000139320.78673.2a","article-title":"Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial","volume":"172","author":"Andriole","year":"2004","journal-title":"J Urol"},{"key":"10.1002\/14651858.CD007091-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.juro.2006.07.045","article-title":"Prostate cancer prevention and finasteride","volume":"176","author":"D'Amico","year":"2006","journal-title":"J Urol"},{"key":"10.1002\/14651858.CD007091-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1002\/14651858.CD007091-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analysis","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD007091-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/djm117","article-title":"Finasteride and High-Grade Prostate Cancer in the PCPT","volume":"99","author":"Lucia SM Epstein","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/14651858.CD007091-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/jnci\/djj307","article-title":"Effect of finasteride on the sensitivity of PSA for detecting prostate cancer","volume":"98","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/14651858.CD007091-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.juro.2007.01.071","article-title":"Finasteride improves the sensitivity of digital rectal examination for prostate cancer prevention","volume":"177","author":"Thompson","year":"2007","journal-title":"J Urol"},{"key":"10.1002\/14651858.CD007091-BIB0023|cit23","volume-title":"Comparison of Therapies for Clinically Localized Prostate Cancer. Evidence Report\/Technology Assessment No. xxx (Prepared by the Minnesota Evidence-based Practice Center under Contract No. 290-02-0009.)","author":"Wilt","year":"2008 (in press)"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD007091\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T10:15:04Z","timestamp":1721902504000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007091"}},"subtitle":[],"editor":[{"name":"Cochrane Urology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,4,23]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007091","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,23]]}}}